Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Nov 21;21(43):12505-9.
doi: 10.3748/wjg.v21.i43.12505.

Cholestasis, ascites and pancytopenia in an immunocompetent adult with severe cytomegalovirus hepatitis

Affiliations
Case Reports

Cholestasis, ascites and pancytopenia in an immunocompetent adult with severe cytomegalovirus hepatitis

Jun-Yan Qian et al. World J Gastroenterol. .

Abstract

Human cytomegalovirus (CMV) is a herpesvirus, which establishes lifelong latency after primary infection and leads to severe disease in immunocompromised patients. However, CMV infection in immunocompetent patients is usually asymptomatic and severe organ damage is rarely reported. We report a case of severe CMV hepatitis in an immunocompetent patient presenting with cholestasis, portal hypertension-related ascites and pancytopenia. The patient was asymptomatic with normal liver function and negative CMV DNA after two weeks of antiviral therapy. This case is an example of a common infection with an uncommon presentation, and suggests that testing for CMV should be carried out, even in patients with normal immune status, presenting with severe liver damage or cholestasis.

Keywords: Ascites; Cholestasis; Cytomegalovirus hepatitis; Immunocompetent adult; Pancytopenia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Findings on imaging. PET (A), transverse CT (B), PET/CT fusion image (C) and maximum intensity projection (MIP, D) image of the whole body using fluorodeoxyglucose PET/CT (FDG PET/CT) demonstrate a large hypermetabolic deposit in the liver (standardized uptake value - SUVmax = 8.3 cm2/mL). PET: Positron emission tomography; CT: Computed tomography.
Figure 2
Figure 2
Biomedical profile during hospitalization. The graph shows the changing pattern of body temperature (T), alanine aminotransferase (ALT), direct bilirubin (DBil) and platelet count (PLT) before and after antiviral therapy.

References

    1. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4:725–738. - PubMed
    1. Pass RF. Epidemiology and transmission of cytomegalovirus. J Infect Dis. 1985;152:243–248. - PubMed
    1. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis. 1992;166:1223–1227. - PubMed
    1. Brennan DC. Cytomegalovirus in renal transplantation. J Am Soc Nephrol. 2001;12:848–855. - PubMed
    1. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47. - PMC - PubMed

Publication types

MeSH terms